Amniotics AB (publ) (AMNI.ST)
SEK 0.01
(5.88%)
SEK 0.01
(5.88%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 534 Thousand SEK | 8363.7% |
| 2022 | -6462.00 SEK | -224.56% |
| 2021 | -1991.00 SEK | -1.07% |
| 2020 | -1970.00 SEK | -46.43% |
| 2019 | -1345.40 SEK | 99.51% |
| 2018 | -276.7 Thousand SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q4 | 534 Thousand SEK | 0.0% |
| 2023 Q3 | 534 Thousand SEK | 7829.05% |
| 2023 Q1 | - SEK | 100.0% |
| 2023 Q2 | -6909.00 SEK | 0.0% |
| 2023 FY | 534 Thousand SEK | 8363.7% |
| 2022 Q1 | -2.05 Million SEK | -3.21% |
| 2022 Q4 | -6462.00 SEK | 99.38% |
| 2022 FY | -6462.00 SEK | -224.56% |
| 2022 Q3 | -1.04 Million SEK | 40.17% |
| 2022 Q2 | -1.74 Million SEK | 15.33% |
| 2021 Q4 | -1.99 Million SEK | -60.95% |
| 2021 FY | -1991.00 SEK | -1.07% |
| 2021 Q3 | -1.23 Million SEK | -15.72% |
| 2021 Q1 | -2000.00 SEK | 0.0% |
| 2021 Q2 | -1.06 Million SEK | -53350.0% |
| 2020 Q4 | - SEK | 0.0% |
| 2020 FY | -1970.00 SEK | -46.43% |
| 2020 Q1 | - SEK | 0.0% |
| 2019 FY | -1345.40 SEK | 99.51% |
| 2018 FY | -276.7 Thousand SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alligator Bioscience AB (publ) | 2.00 SEK | -26699900.0% |
| Ziccum AB (publ) | -4.18 Million SEK | 112.748% |
| Modus Therapeutics Holding AB (publ) | - SEK | -Infinity% |
| BioArctic AB (publ) | - SEK | -Infinity% |
| Sprint Bioscience AB (publ) | -7.13 Million SEK | 107.483% |
| Mendus AB (publ) | - SEK | -Infinity% |
| Genovis AB (publ.) | 14.9 Million SEK | 96.417% |
| Intervacc AB (publ) | 10.48 Million SEK | 94.906% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | - SEK | -Infinity% |
| Active Biotech AB (publ) | -2500.00 SEK | 21460.0% |
| Magle Chemoswed Holding AB (publ) | 35.22 Million SEK | 98.484% |
| Bio-Works Technologies AB (publ) | 9.06 Million SEK | 94.111% |
| Aptahem AB (publ) | - SEK | -Infinity% |
| Vicore Pharma Holding AB (publ) | - SEK | -Infinity% |
| Kancera AB (publ) | -1950.00 SEK | 27484.615% |
| Infant Bacterial Therapeutics AB (publ) | - SEK | -Infinity% |
| Fluicell AB (publ) | 3.15 Million SEK | 83.048% |
| Saniona AB (publ) | 1.00 SEK | -53399900.0% |
| Lipigon Pharmaceuticals AB (publ) | -1.62 Million SEK | 132.841% |
| Biovica International AB (publ) | 2.19 Million SEK | 75.716% |
| Spago Nanomedical AB (publ) | 1.00 SEK | -53399900.0% |
| AcouSort AB (publ) | 2.08 Million SEK | 74.327% |
| Xintela AB (publ) | 398 Thousand SEK | -34.171% |
| Abliva AB (publ) | - SEK | -Infinity% |
| Egetis Therapeutics AB (publ) | 700 Thousand SEK | 23.714% |
| Karolinska Development AB (publ) | - SEK | -Infinity% |
| OncoZenge AB (publ) | -862.99 Thousand SEK | 161.877% |
| 2cureX AB (publ) | -1000.00 SEK | 53500.0% |
| CombiGene AB (publ) | -1.79 Million SEK | 129.683% |
| Asarina Pharma AB (publ) | - SEK | -Infinity% |
| Calliditas Therapeutics AB (publ) | 20.42 Million SEK | 97.386% |
| Camurus AB (publ) | 100.95 Million SEK | 99.471% |
| Corline Biomedical AB | -3.85 Million SEK | 113.845% |
| IRLAB Therapeutics AB (publ) | 1000.00 SEK | -53300.0% |
| Isofol Medical AB (publ) | - SEK | -Infinity% |
| I-Tech AB | 4.28 Million SEK | 87.523% |
| Hansa Biopharma AB (publ) | 9.79 Million SEK | 94.547% |
| Cyxone AB (publ) | - SEK | -Infinity% |
| ExpreS2ion Biotech Holding AB (publ) | - SEK | -Infinity% |
| Biosergen AB | -4.92 Million SEK | 110.834% |
| Cantargia AB (publ) | - SEK | -Infinity% |
| NextCell Pharma AB | 545.23 Thousand SEK | 2.061% |
| Xspray Pharma AB (publ) | 43.78 Million SEK | 98.78% |
| Elicera Therapeutics AB (publ) | -446.98 Thousand SEK | 219.467% |
| Nanologica AB (publ) | 2.97 Million SEK | 82.038% |
| SynAct Pharma AB | - SEK | -Infinity% |
| Annexin Pharmaceuticals AB (publ) | - SEK | -Infinity% |
| Stayble Therapeutics AB (publ) | -321.14 Thousand SEK | 266.28% |
| LIDDS AB (publ) | - SEK | -Infinity% |
| Lipum AB (publ) | - SEK | -Infinity% |
| BioInvent International AB (publ) | 11.84 Million SEK | 95.491% |
| Alzinova AB (publ) | -3.27 Million SEK | 116.29% |
| Oncopeptides AB (publ) | 2.42 Million SEK | 77.979% |
| Pila Pharma AB (publ) | 1.00 SEK | -53399900.0% |
| Guard Therapeutics International AB (publ) | -1486.00 SEK | 36035.397% |
| Scandinavian ChemoTech AB (publ) | 4.03 Million SEK | 86.763% |
| Simris Alg AB (publ) | 1.09 Million SEK | 51.054% |
| Diamyd Medical AB (publ) | 24.05 Million SEK | 97.78% |
| Xbrane Biopharma AB (publ) | 106.85 Million SEK | 99.5% |
| Ascelia Pharma AB (publ) | - SEK | -Infinity% |
| Diagonal Bio AB (publ) | 1.02 Million SEK | 48.054% |